UNSPSC 51342603: Fomivirsen sodium

This classification denotes an antisense agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Z6W3S36X5. European Medicines Agency schedules Fomivirsen sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02253MIG. Fomivirsen sodium generally arises in the molecular formula C204H243N63O114P20S20.20NA. The term 'fomivirsen sodium' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule fomivirsen sodium under HS 29349990 and SITC 51579.

Fomivirsen sodium bears US NLM identifiers UMLS ID C0982166 and NCI Concept Code C61770. SMILES: As of Q4 2014, FOMIVIRSEN SODIUM remains US FDA's Preferred Term for this commodity.

UNSPSC 51342603 Fomivirsen sodium is a Commodity code that nominally identifies a specific antiviral pharmaceutical agent, but recent state and local solicitations tagged with this code show little relevant activity and instead reflect a broad mismatch between the code's scope and actual procurement posted under it. The most recent opportunities under this code involve naloxone kits, first-aid supplies for emergency responders, generic multi-source pharmaceuticals and over-the-counter products distributed through cooperative purchasing, and direct-to-manufacturer prescription program inquiries—none of which align with fomivirsen sodium's actual therapeutic use. State and local procurement offices appear to be using this code as a catch-all for pharmaceutical and medical supply procurement across health departments, county emergency services, fire departments, and state health agencies, rather than sourcing the antiviral drug specifically.

Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other participants). Recent posted opportunities span Florida, Texas, and Minnesota, with representative examples including Seminole County's IFB for 1,900 naloxone units and 800 drug deactivation systems annually (response due July 26, 2023, though the posting date is listed as June 30, 2026), the City of Tampa's sealed-bid procurement for 169 line items of medical and first aid supplies for the Fire Department Rescue Division (response due March 13, 2026, estimated contract value $700,000, with a 5% small local business enterprise discount available), and Minnesota MMCAP's RFP for generic pharmaceuticals and OTC products through three authorized wholesalers with proposals due March 26, 2026. The code shows activity across diverse state and local agencies but does not consistently reflect fomivirsen sodium procurement; business development professionals should verify actual commodity alignment before pursuit.